Cancer radiation therapies anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Organs at Risk Tumor Cells, Cultured Glottis Cell Line HCT116 Cells HT29 Cells MCF-7 Cells Neoplastic Stem Cells

Organisms3

Mice, Nude Mice, Inbred BALB C Mice, SCID

Diseases52

Radiation Injuries Neoplasms Radiation Pneumonitis Neoplasms, Radiation-Induced Breast Neoplasms Radiation Injuries, Experimental Prostatic Neoplasms Neoplasm Recurrence, Local Brain Neoplasms Head and Neck Neoplasms Lung Neoplasms Carcinoma, Squamous Cell Radiodermatitis Adenocarcinoma Neoplasm Metastasis Colonic Neoplasms Carcinoma, Non-Small-Cell Lung Pancreatic Neoplasms Ovarian Neoplasms Rectal Neoplasms Uterine Cervical Neoplasms Carcinoma Neoplasm Invasiveness Neoplasms, Second Primary Glioblastoma Stomach Neoplasms Acute Radiation Syndrome Glioma Disease Progression Bone Neoplasms Liver Neoplasms Sarcoma Hodgkin Disease Pelvic Neoplasms Leukemia, Radiation-Induced Nasopharyngeal Neoplasms Esophageal Neoplasms Neoplasms, Experimental Skin Neoplasms Brain Stem Neoplasms Urinary Bladder Neoplasms Cerebellar Neoplasms Colorectal Neoplasms Melanoma Neovascularization, Pathologic Thoracic Neoplasms Osteoradionecrosis Carcinoma, Small Cell Cell Transformation, Neoplastic Spinal Neoplasms Medulloblastoma Laryngeal Neoplasms

Chemicals and Drugs55

Antineoplastic Agents Radiation-Sensitizing Agents Cisplatin Doxorubicin Antineoplastic Agents, Phytogenic Radiation-Protective Agents Fluorouracil Cobalt Radioisotopes Paclitaxel Antibiotics, Antineoplastic Etoposide Prostate-Specific Antigen Tumor Suppressor Protein p53 Neoplasm Proteins Antimetabolites, Antineoplastic Camptothecin Drug Carriers Dacarbazine Androgen Antagonists Tumor Markers, Biological Antineoplastic Agents, Alkylating Vinblastine Vincristine Bleomycin RNA, Messenger RNA, Small Interfering Deoxycytidine Cancer Vaccines Ellipticines Enzyme Inhibitors Carboplatin DNA, Neoplasm Cesium Radioisotopes P-Glycoprotein Organoplatinum Compounds Radiopharmaceuticals DNA-Binding Proteins Radioisotopes Antibodies, Monoclonal Amifostine Iridium Radioisotopes Prodrugs Mitomycin Proto-Oncogene Proteins c-bcl-2 Antineoplastic Agents, Hormonal Cyclophosphamide Radioactive Fallout Nimustine DNA Taxoids Mechlorethamine Anticarcinogenic Agents Plant Extracts Tumor Suppressor Proteins Receptor, Epidermal Growth Factor

Analytical, Diagnostic and Therapeutic Techniques and Equipment87

Radiation Dosage Dose-Response Relationship, Radiation Radiotherapy Radiotherapy Dosage Combined Modality Therapy Radiotherapy, Conformal Radiation Monitoring Radiotherapy, Intensity-Modulated Dose Fractionation Radiotherapy, Adjuvant Radiotherapy Planning, Computer-Assisted Brachytherapy Radiometry Drug Screening Assays, Antitumor Radiation Injuries, Experimental Radiosurgery Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Radiotherapy, Computer-Assisted Neoplasm Staging Cranial Irradiation Retrospective Studies Survival Analysis Radiotherapy, Image-Guided Particle Accelerators Survival Rate Xenograft Model Antitumor Assays Disease-Free Survival Follow-Up Studies Radiotherapy, High-Energy Prognosis Tumor Burden Chemotherapy, Adjuvant Chemoradiotherapy Early Detection of Cancer Tomography, X-Ray Computed Drug Delivery Systems Mastectomy, Segmental Neoplasm Transplantation Clinical Trials as Topic Prospective Studies Actuarial Analysis Mastectomy Drug Carriers SEER Program Lymphatic Irradiation Kaplan-Meier Estimate Four-Dimensional Computed Tomography Blotting, Western Risk Assessment Transplantation, Heterologous Models, Biological Radiation Hybrid Mapping Risk Drug Administration Schedule Molecular Targeted Therapy Inhibitory Concentration 50 Reverse Transcriptase Polymerase Chain Reaction Prostatectomy Neoplasms, Experimental Reproducibility of Results Positron-Emission Tomography Risk Factors Phantoms, Imaging Palliative Care Sensitivity and Specificity Gene Expression Profiling Flow Cytometry Feasibility Studies Synchrotrons Radiotherapy Setup Errors Whole-Body Irradiation Drug Design Multivariate Analysis Magnetic Resonance Imaging Proton Therapy Transfection Karnofsky Performance Status Body Burden Hyperthermia, Induced Organ Sparing Treatments Cone-Beam Computed Tomography Film Dosimetry Drug Evaluation, Preclinical Neoplasm Grading Registries Tumor Stem Cell Assay

Phenomena and Processes39

Radiation Dosage Radiation, Ionizing Dose-Response Relationship, Radiation Radiation Tolerance Radiation Gamma Rays Cosmic Radiation Apoptosis Cell Survival Drug Resistance, Neoplasm Background Radiation DNA Damage Ultraviolet Rays Time Factors Radiation Effects Gene Expression Regulation, Neoplastic Cell Proliferation Dose-Response Relationship, Drug Cell Cycle X-Rays DNA Repair Linear Energy Transfer Mutation Cell Division Risk Inhibitory Concentration 50 Drug Synergism Signal Transduction Beta Particles Drug Resistance, Multiple Sensitivity and Specificity Down-Regulation Transfection Photons Cell Death Sunlight Molecular Structure Phosphorylation Radiation, Nonionizing

Disciplines and Occupations5

Radiation Oncology Radiobiology Medical Oncology Drug Design Radiation Genetics

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Nuclear Warfare

Technology, Industry, Agriculture1

Information Science8

Radiotherapy, Conformal Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Radiotherapy, Computer-Assisted Survival Rate SEER Program Molecular Sequence Data Registries

Named Groups1

Health Care41

Radiation Injuries Radiation Dosage Dose-Response Relationship, Radiation Radiation Protection Radiation Monitoring Radiation Injuries, Experimental Treatment Outcome Cosmic Radiation Retrospective Studies Survival Analysis Survival Rate Disease-Free Survival Follow-Up Studies Ultraviolet Rays Radiation Effects Clinical Trials as Topic Acute Radiation Syndrome Prospective Studies Actuarial Analysis SEER Program Radioactive Hazard Release Kaplan-Meier Estimate Relative Biological Effectiveness Risk Assessment Risk Reproducibility of Results Risk Factors Palliative Care Sensitivity and Specificity National Cancer Institute (U.S.)Feasibility Studies Age Factors Radiotherapy Setup Errors Multivariate Analysis Radioactive Fallout Karnofsky Performance Status Body Burden Radiation Genetics Film Dosimetry Sunlight Registries

Geographicals2

United States Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Radiation Injuries Radiation Dosage Radiation, Ionizing Dose-Response Relationship, Radiation Radiation Tolerance Radiotherapy Radiotherapy Dosage Antineoplastic Agents Radiation Combined Modality Therapy Radiation Oncology Radiation Protection Radiotherapy, Conformal Radiation Monitoring Radiotherapy, Intensity-Modulated Neoplasms Dose Fractionation Radiotherapy, Adjuvant Radiotherapy Planning, Computer-Assisted Radiation Pneumonitis Cell Line, Tumor Neoplasms, Radiation-Induced Brachytherapy Radiation-Sensitizing Agents Radiometry Breast Neoplasms Drug Screening Assays, Antitumor Radiation Injuries, Experimental Prostatic Neoplasms Radiosurgery Gamma Rays Cisplatin Treatment Outcome Neoplasm Recurrence, Local Cosmic Radiation Brain Neoplasms Antineoplastic Combined Chemotherapy Protocols Head and Neck Neoplasms Apoptosis Lung Neoplasms Cell Survival Radiotherapy, Computer-Assisted Neoplasm Staging Drug Resistance, Neoplasm Mice, Nude Carcinoma, Squamous Cell Cranial Irradiation Doxorubicin Retrospective Studies Survival Analysis Radiotherapy, Image-Guided Particle Accelerators Antineoplastic Agents, Phytogenic Survival Rate Xenograft Model Antitumor Assays Radiation-Protective Agents Radiodermatitis Background Radiation Disease-Free Survival Follow-Up Studies DNA Damage Radiotherapy, High-Energy Fluorouracil Adenocarcinoma Prognosis Ultraviolet Rays Time Factors Organs at Risk Tumor Burden Tumor Cells, Cultured Chemotherapy, Adjuvant Neoplasm Metastasis Colonic Neoplasms Chemoradiotherapy Early Detection of Cancer Cobalt Radioisotopes Paclitaxel Carcinoma, Non-Small-Cell Lung Tomography, X-Ray Computed Antibiotics, Antineoplastic Radiation Effects Pancreatic Neoplasms Gene Expression Regulation, Neoplastic Cell Proliferation Ovarian Neoplasms Drug Delivery Systems Rectal Neoplasms Radiobiology Mastectomy, Segmental Uterine Cervical Neoplasms Carcinoma Etoposide Dose-Response Relationship, Drug Cell Cycle Neoplasm Invasiveness X-Rays Prostate-Specific Antigen Tumor Suppressor Protein p53 Neoplasm Transplantation Clinical Trials as Topic

No FAQ available that match "cancer radiation therapies anticancer drugs or radiation"